Germany’s coalition government has unveiled a plan to legalize recreational cannabis for adults — a move that would make it only the second country in the European Union to do so, after Malta. Health Minister Karl Lauterbach announced the proposal, which still requires approval from parliament and review by the European Commission before it can become law.
At a glance
- Possession limits: Adults would be allowed to carry up to about 1 ounce of cannabis for personal use under the proposed rules.
- Legal cannabis sales: Licensed shops and pharmacies would be permitted to sell cannabis, alongside a government cannabis tax added to the standard sales tax.
- Home cultivation: Each adult would be allowed to grow up to three cannabis plants at home for personal use.
Why Germany is making this move
Lauterbach was direct about the reasoning. The existing ban on cannabis had shown “no evident success,” he said, with consumption rising in recent years alongside drug addiction rates among adults. The goal is not to loosen controls on cannabis — it’s to regulate the market firmly, he stressed.
Protecting young people sits at the center of the public health argument. The government is considering restricting the maximum potency of cannabis products sold to adults under 21, specifically by monitoring levels of THC, the main psychoactive compound. It also plans to expand public information campaigns about cannabis risks, with particular focus on younger users.
Advertising and mailing of cannabis would remain prohibited under the plan. The government frames regulated legal sales as a way to move cannabis away from uncontrolled black markets, where product strength and safety are impossible to oversee.
Where Germany fits in the global picture
Within the E.U., only Malta has fully legalized recreational cannabis. The Netherlands — often associated with cannabis tolerance — has not gone as far: Dutch law tolerates cannabis sales in small quantities at “coffee shops,” but broader recreational use remains technically illegal. Switzerland has decriminalized possession of low-THC cannabis; Portugal decriminalized personal use of all illicit drugs back in 2001 C.E.; Italy and France have more restrictive frameworks still.
Beyond Europe, Canada and Uruguay have both legalized recreational cannabis nationally. In the U.S., 37 states and Washington D.C. had legalized medical cannabis at the time of the announcement, while 19 states had approved recreational use — representing well over 40% of the U.S. population.
The German proposal was part of the coalition government’s founding manifesto. The Social Democrats lead the coalition, with the Greens and the liberal Free Democrats as partners — and all three parties backed the legalization commitment from the start.
Hurdles still ahead
The plan is not yet law. It needs to clear the German parliament and also pass review by the European Commission to ensure it complies with E.U. treaties. The Schengen Agreement, which governs free travel across 26 countries, adds another layer of complexity: it requires even medicinal cannabis users to carry documentation when crossing borders.
Opposition is real. Bavaria’s conservative government condemned the proposal, with CSU politician Klaus Holetschek warning it “sends a dangerous signal not only to Germany, but to the whole of Europe” and raising concerns about drug tourism flowing into the country.
The science, too, carries caveats. Some studies have linked potent cannabis strains to an increased risk of psychosis, particularly in younger people, and regular cannabis use carries a documented addiction risk. The health debate remains unsettled, which is part of why the proposed age-based THC limits and public health campaigns matter as much as the legalization framework itself.
A model for Europe — or a warning?
How Germany’s experiment unfolds could influence the policy debate across the continent. A large, central E.U. economy legalizing cannabis through licensed retail channels is a fundamentally different proposition than a small island nation doing so. It will be watched closely by governments on both sides of the debate.
Lauterbach put it plainly: prohibition has not worked. Whether a regulated market does better — for public health, for young people, and for the credibility of drug policy more broadly — is a question Germany is now preparing to answer in practice.
Read more
For more on this story, see: BBC News
For more from Good News for Humankind, see:
- Alzheimer’s risk cut in half by drug in landmark prevention trial
- U.K. cancer death rates down to their lowest level on record
- The Good News for Humankind archive on Germany
About this article
- 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
- 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
- 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
- ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
